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ABSTRACT 14 
In the present research, urea complexation was used to concentrate n-3 fatty acids (FA) 15 
from crude and refined commercial salmon oils. The experimental procedure included 16 
salmon oil saponification, free fatty acid (FFA) collection, formation of urea-FFA 17 
inclusion complexes, extraction of free n-3 FA and further analysis by gas-liquid 18 
chromatography of the corresponding FA methyl esters. As a result, differences 19 
between crude and refined salmon oil could be observed. Thus, crude oil provided 20 
higher typical odour, viscosity and suspension particle values. Concerning chemical 21 
analyses, crude salmon oil showed a higher FFA content and iodine value. Related to 22 
physical colour assessment, refined salmon oil showed lower a* and b* scores when 23 
compared to its counterpart crude oil. A high yield of n-3 FA recovering could be 24 
observed in both cases, which confirmed salmon oil to be a profitable source of such 25 
highly valuable constituents. Factors such as temperature of reaction and urea-FFA ratio 26 
showed to be markedly significant in order to achieve a higher value concentration.  27 
28 
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INTRODUCTION 31 
Marine species have attracted considerable attention as a source of high amounts of 32 
valuable nutritional components to the human health and nutrition. Among them, 33 
essential fatty acids corresponding to the n-3 series have attracted an increasing 34 
attention, being cis-5,8,11,14,17-eicosapentaenoic acid (EPA) and cis-4,7,10,13,16,19-35 
docosahexaenoic acid (DHA) the most abundant components (ACKMAN & 36 
RATNAYAKE 1990). Marine organisms are recognised as the most important natural 37 
sources of such polyunsaturated fatty acid (PUFA) series, this arising from the marine 38 
phytoplankton, as primary producer, and then following the tropic chain up to marine 39 
invertebrates and fish (GREENE & SELIVONCHICK 1987).  40 
In recent years, evidence that fish-consuming populations have a low prevalence of 41 
coronary heart, circulatory and inflammation diseases has generated a great deal of 42 
interest on fish oils; in this sense, PUFA presence has been recognised as specially 43 
responsible for this positive behaviour (SIMOPOULOS 1991). Thus, Clupeidae, 44 
Scombridae and Salmonidae are recognised as the fish families with the highest 45 
percentages of EPA and DHA in the foodstuff portion. Among them, Coho salmon 46 
(Oncorhynchus kisutch) has received a great attention because of its increasing farming 47 
production (FAO 2007a) in parallel to important capture production (FAO 2007b); 48 
additionally, high and profitable n-3 PUFA contents have been reported for this species 49 
(AUBOURG et al. 2005; VINAGRE et al. 2011). 50 
Several methods have been reported for concentrating PUFA in marine oils, with varied 51 
yields (HAAGSMA et al. 1982; ZUTA et al. 2003; RUBIO-RODRÍGUEZ et al. 2010). 52 
Among them, urea complexation has been applied extensively, as allowing handling of 53 
large quantities of materials in simple equipment and being a relatively inexpensive 54 
method (RUBIO-RODRÍGUEZ et al. 2010). In the present research, urea complexation 55 
was used to concentrate n-3 PUFA from crude (raw) and refined commercial Coho 56 
salmon oils; comparison of results obtained from both kinds of oils was achieved.57 
58 
MATERIAL AND METHODS 59 
Raw material and chemicals employed. Crude (total n-3 fatty acids > 12 %) and 60 
refined salmon oil were obtained from Salmonoil S.A. (Puerto Montt, Chile). Fatty acid 61 
methyl esters (FAME) standards and fatty acid (FA) standards were purchased from 62 
NU-CHEK PREP, INC (Elysian, USA), these including methyl esters of 52 different 63 
FA ranging between C4:0 and C24:1 (GLC Reference standard 463; Lot 021-U). 1,2,3- 64 
Tritricosanoin (CAS: 86850-72-8) was employed as internal standard. Urea, ethanol, n-65 
hexane, methanol, and -tocopherol employed were analytical grade and obtained from 66 
Merck (Santiago, Chile).67 
68 
Characterization of crude and refined salmon oil. Characterization of starting crude 69 
and refined salmon oils was carried out by assessment of free fatty acids (FFA; AOCS 70 
1993, official method Ca 5a-40), conjugated dienes (CD) and trienes (CT) (KIM & 71 
LABELLA 1987), peroxide value (PV; AOCS 1993, official method Cd 8b-90), 72 
anisidine value (AV; AOCS 1993, official method Cd 18-19), insoluble impurities 73 
(AOCS 1993, official method Ca 3a-46), unsaponifiable matter (UM; AOCS 1993, 74 
official method Ca 6b-53), iodine value (IV; AOCS 1993, official method Cd 1-25), 75 
moisture and volatile matter (AOCS 1993, official method Ca 2d-25) and colour 76 
parameters (L*, a*, b* values by Hunterlab method; VINAGRE et al. 2011).  77 
78 
Preparation of FAME. For analysis of FA composition on triglycerides (TG) by GLC, 79 
sodium methylate was added into the salmon oil or n-3 concentrates. Then, the 1,2,3-80 
tritricosanoin (23:0-23:0-23:0 TG) solved in n-hexane was added as internal standard in 81 
the sample. In order to convert the TG fatty acids into FAME, 10mL of sodium 82 
methylate and 50L of internal standard (100mg/mL) were added. A fused silica 83 
capillary column 100m×0.25mm i.d., coated with SPTM-2560 was employed. GLC 84 
setting conditions were as following: injection temperature at 250 ºC, flame ionisation 85 
detector (FID) temperature at 250 ºC, flow rate of carrier gas (N2) of 1.2 mL/min, and 86 
oven temperature from 160 ºC to 220 ºC with an increasing rate of 2 ºC/min. DataApex 87 
ClarityTM software for chromatogram analysis was used. The concentration of FAME 88 
was determined from the relation to the internal standard added (1, 2, 3-Tritricosanoin: 89 
Internal standard) by assessment of the peak/area ratio. Quantification of all kinds of 90 
FA was achieved according to the AOCS Official Method (AOCS 2009, Ce 1j-7). 91 
92 
Free n-3 PUFA concentration from salmon oil. The procedure included salmon oil 93 
saponification, FFA collection, formation of urea-FFA inclusion complexes, and 94 
extraction of free n-3 PUFA. The final concentrated n-3 PUFA was flushed with 95 
nitrogen and stored at -70ºC with 100 ppm of -tocopherol (HAAGSMA et al. 1982; 96 
ZUTA et al. 2003).  EPA and DHA, ratio on variations of total n-3 PUFA, and trans FA 97 
were determined.  98 
99 
Statistical analysis. Physical and chemical analyses were performed in triplicate (n=3). 100 
The 95% con®dence intervals of each quality parameter was calculated, taking into 101 
account the number of replications and considering the standard deviation (SD) of each 102 
sample. Results obtained were analysed by a multifactorial analysis of variance 103 
(MANOVA). In case of significant differences, a multiple range comparison was 104 
carried out by means of the Tukey test. Statgraphics Plus 5.1 software (Manugistics 105 
Inc., Rockville, USA) was used. 106 
107 
RESULTS AND DISCUSSION 108 
Table 1 shows the characterization of the starting crude (raw) and refined oil from 109 
salmon. Quality differences as a result of the refining process can be observed. 110 
Concerning chemical analyses, crude salmon oil showed a higher FFA content and IV. 111 
Related to physical colour assessment, refined salmon oil showed lower a* (redness 112 
loss) and b* (yellowness loss) values when compared to its counterpart crude oil.  113 
With the aim of being fit for human nutrition, fat composition should not exceed 114 
relevant limitations expressed in legislation. According to MINSAL (2012), accepted 115 
values of FFA in oil for human consumption should be lower than 0.25% (expressed as 116 
oleic acid) and fin the case of the PV scores should be lower than 10 meq active 117 
oxygen/kg oil. Meantime, values lower than score 20 are required for the AV (GOED 118 
2012). Accordingly, both kinds of present oils agree with such nutritional requirements. 119 
FAME chromatograms belonging to commercial crude and refined salmon oil and their 120 
n-3 FA concentrates are given in Figure 1. The effect of urea on percentage of n-3 FA in 121 
the crude (B) and refined (D) concentrates can be observed. Thus, the n-3 FA 122 
concentrate content increased due low-temperature crystallization and the urea inclusion 123 
compound formation. The urea fractionation of the fatty acids is mainly based on the 124 
degree of unsaturation: the more unsaturated, the less they will be included in the urea 125 
crystals (HAAGSMA et al. 1982).  126 
Crude and refined salmon oil compositions, as well as their concentrate counterparts 127 
(g/100g FAME) are shown in Table 2.  128 
The most abundant fatty acids found in crude salmon oil (g/100g oil): C 14:0 (1.97), C 129 
16:0 (8.07), C 16:1 9C (2.69), C 18:0 (2.26), C 18:1 9C (17.27), C 18:2 9C12C (9.49), 130 
C 18:3 n3; -linolenic (2.02), C 20:5 (2.89), C 22:5 (1.40) and C 22:6 (3.06). Whereas 131 
FA showing a higher presence in refined salmon oil were (g/100g oil): C 14:0 (1.56), C 132 
16:0 (6.48), C 16:1 9C (2.22), C 18:0 (1.78), C 18:1 9C (13.81), C 18:2 9C12C (7.64), 133 
C 18:3 C 18:3 n3; -linolenic (16.69), C 20:5 (2.37), C 22:5 (1.11) and C 22:6 (2.49). 134 
Crude and refined salmon oil trans FA contents (g/100g oil) were C 16:1 9T (0.13 and 135 
0.11), C 18:2 9C12T (0.08 and 0.07), C 18:2 9T12C (0.02 and 0.03) showing contents 136 
of 0.40 and 0.44 when expressed as g/100g FAME, respectively (Table 3).  137 
AUBOURG et al. (2005) found that the most abundant FA in coho salmon farmed in 138 
the South of Chile were C 18:1 n9 and C 16:0 fatty acids (19.3 and 20.7 g/100 g total 139 
FAME, respectively), followed by C 22:6 n3, C 16:1 n7 and C 20:5 n3 (14.8, 7.7 and 140 
7.1 g/100 g total FAME, respectively).  141 
In the present research, composition of crude salmon oil FA concentrate was (g/100g 142 
oil): C 14:0 (0.14), C 16:0 (0.06), C 16:1 9C (1.66), C 18:0 (0.48), C 18:1 9C (1.73), C 143 
18:2 9C12C (11.2), C 18:3 C 18:3 n3; -linolenic (2.81), C 20:5 (5.59), C 22:5 (2.26) 144 
and C 22:6 (6.23); whereas composition of refined salmon oil fatty acid concentrate was 145 
(g/100g oil): C 14:0 (0.45), C 16:0 (0.34), C 16:1 9C (3.18), C 18:0 (0.04), C 18:1 9C 146 
(7.42), C 18:2 9C12C (20.24), C 18:3 C 18:3 n3; -linolenic (4.47), C 18:4 (2.03), C 147 
20:2 (1.84), C 20:5 (10.66), C 22:5 (3.95) and C 22:6 (13.42). The crude and refined 148 
salmon oil trans fatty acid concentrates were C 16:1 9T (0.008 and 0), C 18:2 9C12T 149 
(0.08 and 0.16),  C 18:2 9T12C (0 and 0.11) showing contents of 0.23 and 0.36 when 150 
expressed as g/100g FAME, respectively (Table 3).  151 
Saturated fatty acid content decreased after urea inclusion whereas unsaturated fatty 152 
acid content increased specially in the case of the n-3 fatty acids. Saturated fatty acids of 153 
refined and crude oil such as C 12:0, C 14:0 and C 18:0, as well as monounsaturated 154 
fatty acids such as C 18:1 9C formed adducts due to urea inclusion. 155 
The total PUFA content of crude and refined salmon oil concentrate was 31.10 and 55.56 156 
g/100g oil, respectively, being the EPA+ DHA content of 11.82 and 24.08 g/100g oil, 157 
respectively. 158 
The crude and refined oil concentrate presented 0.09 and 0.28 g of trans FA/100g oil, 159 
respectively. The trans FA content from industrial sources in food must be lower than 160 
2% of the total fat content of the product. 161 
According to HAAGSMA et al. (1982), a maximal efficiency of 82% was found when 162 
the urea/FA (w/w) ratio was near to score 3. Similar results were observed in the present 163 
research (Table 2). The best result obtained for the total n-3 PUFA of refined salmon oil 164 
concentrate was 51.3 g/100g FAME, this containing 36.31 g/100g oil (Table 3). 165 
Related to the n-3 PUFA concentration, a high yield of n-3 PUFA recovering could be 166 
observed in all cases, which confirmed salmon oil to be a profitable source of such 167 
highly valuable constituents. Factors such as temperature of reaction and urea-FFA ratio 168 
showed to be markedly significant in order to achieve a higher value concentration. 169 
170 
CONCLUSIONS 171 
The composition and properties of crude and refined fish oil and their corresponding n-3 172 
concentrates showed to depend on the composition of the raw material employed. As a 173 
result, differences between crude and refined salmon oil could be observed. Thus, crude 174 
oil provided higher a* and b* colour values. Concerning chemical analyses, crude 175 
salmon oil showed a higher FFA content and IV. Related to physical colour assessment, 176 
refined salmon oil showed lower a* (redness loss) and b* (yellowness loss) values when 177 
compared to its counterpart crude oil. Related to n-3 PUFA concentration, a high yield 178 
of n-3 PUFA recovering could be observed in all cases, which confirmed salmon oil to 179 
be a profitable source of such highly valuable constituents.  180 
181 
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Table 1. Characterization* of the starting crude and refined salmon oil** 
* Mean values (n=3)   standard deviations. 
** For each quality parameter, mean values preceded by different letters (a, b) denote 
significant differences.  
Quality parameter Crude salmon oil Refined salmon oil
Free fatty acids (FFA) a1.78±0.03 b0.24±0.02
Conjugated dienes (CD) a0.006±0.007 a0.019±0.002
Moisture (%) a0.27±0.21 a0.26 ± 0.10
Impurities a0.43±0.28 a0.12±0.02
Iodine value (IV) b196.9±13.3 a154.0±1.1
Conjugated trienes (CT) a0.007±0.006 a0.04 ± 0.04
Peroxide value (PV; meq 
active oxygen/Kg oil) 
a2.73 ± 0.36 b3.54 ± 0.16 
p-anisidine value (AV) a5.33 ± 0.50 a5.14 ± 1.02
Unsaponifiable matter a0.86 ± 0.38 b1.51 ± 0.38
a* colour value a3.1  ± 0.5 b1.13 ± 0.33
b* colour value a7.95 ± 0.49 b6.87 ± 1.12
L* colour value a10.91± 1.20 a11.33 ± 0.73
Table 2. Fatty acid methyl ester (FAME) composition (g/100g FAME) of commercial 
crude and refined salmon oil and their corresponding concentrates 
FA or FA group
Crude 
salmon oil
Concentrated  
crude salmon oil
Refined 
salmon oil
Concentrated  
refined salmon oil
C 12:0 0.10 0.10 0.0 0.07
C 14:0 3.26 0.36 3.20 0.56
C 16:0 13.59 0.15 13.53 0.44
C 16:1 9T 0.23 0.02 0.24 0
C 16:1 9C 4.56 4.29 4.68 4.09
C 16:1 11C 0.07 0.38 0.08 0.08
C 17:0 0.22 0.08 0.25 0
C 16:1 13C 0.13 0.25 0.08 0.17
C 17:1 0.45 0 0.47 1.06
C 18:0 3.87 1.26 3.78 0.06
C 18:1 9C 29.71 4.54 29.43 9.69
C 18:1 11C 2.97 0.58 3.20 0.92
C 18:2 9C12T 0.14 0.21 0.14 0.22
C 18:2 9T12C 0.03 0.08 0.06 0.15
C 18:2 9C12C 16.44 29.64 16.4 26.62
C 18:2 9C15C 0.30 0.50 0.27 0.42
C 20:0 0.27 2.29 0.26 0
C 18:3 n6; -linolenic 0.20 0.55 0.17 0.56
C 20:1 8C 0 0 0.06 0
C 20:1 11C 1.98 1.02 2.02 1.13
C 18:3 n3; -linolenic 3.53 7.49 3.45 5.92
C 18:4 n3 0.73 2.52 0.81 2.55
C20:2 1.43 0 1.42 2.44
C22:0 0.14 0 0.15 0
C 20:3 n6 0.33 0.94 0.33 0.85
C 22:1 0.23 0 0.24 0.01
C 20:3 n3 0.20 0.94 0.19 0.23
C 20:4 n3 0.44 1.23 0.43 1.12
(1) C 23:0 7.50 0 9.20 0
C 22:2 0.16 0.30 0.16 0.21
C 20:5 n3 5.63 16.60 5.73 15.75
C 24:1 0.23 0.08 0.26 0
C22:4 0.10 0.20 0.09 0.17
C 22:5 n3 2.64 6.50 2.59 5.60
C 22:6 n3 5.66 17.60 5.73 18.90
(1)1, 2, 3-Tritricosanoin: Internal standard. 
Table 3.  Fatty acid groups composition of commercial crude and refined salmon oil and 
their corresponding concentrates 
Fatty acid group Crude salmon oil Concentrated crude oil Refined salmon oil Concentrated refined oil 
(g/100g 
FAME) 
(g/100g 
oil) 
(g/100g 
FAME) 
(g/100g 
oil) 
(g/100g 
FAME) 
(g/100g 
oil) 
(g/100g 
FAME) 
(g/100g 
oil) 
EPA + DHA 11.30 5.95 34.21 11.82 11.45 4.87 34.61 24.08
S n-3 PUFA 18.97 10.22 52.89 18.63 19.06 23.39 50.71 35.89
S  PUFA 38.10 21.24 84.97 31.10 37.97 32.18 76.73 55.56
trans FA 0.40 0.23 0.23 0.09 0.44 0.21 0.36 0.28
